Form D · Biotechnology
Motive Biosciences Inc
Webster, TX · CIK 0001793764
Offering snapshot reported Nov 14, 2019 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 1, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 14, 2019 | Initial | $0 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-353317
Accelerator access to advisors/mentors.
Source: Form D, filed Nov 14, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Anthony Morrison | Director |
| Rajen Savjani | Director |
| Jayanthi Sitharam | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
445 Medical Center Blvd
Webster, TX, 77598
Webster, TX, 77598